This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), The Hong Kong University of Science and Technology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 7 
2 out of 657 Years Active: 2023
Title: Changdong Liu: Innovator in Therapeutic Agents
Introduction
Changdong Liu is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of therapeutic agents, particularly in addressing neurodegenerative diseases and HIV treatment. With a total of 2 patents, Liu's work showcases his dedication to advancing medical science.
Latest Patents
Liu's latest patents include innovative compositions and methods for treating various neurodegenerative diseases. His first patent focuses on compounds that target conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The invention also encompasses methods of fermentation of bacterial cells and tautomerization of the compounds. His second patent involves albofungin and its derivatives, which specifically recognize HIV-1 LTR-III G-quadruplex. This invention outlines methods for treating subjects with HIV using these compounds.
Career Highlights
Throughout his career, Changdong Liu has worked with esteemed institutions such as The Hong Kong University of Science and Technology and the Southern Marine Science and Engineering Guangdong Laboratory in Guangzhou. His research has significantly impacted the understanding and treatment of complex diseases.
Collaborations
Liu has collaborated with notable colleagues, including Aifang Cheng and Wenkang Ye. Their combined expertise has contributed to the advancement of therapeutic innovations.
Conclusion
Changdong Liu's work exemplifies the spirit of innovation in the medical field. His patents reflect a commitment to developing effective treatments for serious health conditions. Liu's contributions continue to inspire future research and development in therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile